| 臺大學術典藏 |
2018-09-10T05:48:30Z |
Cost-effectiveness of different advanced life support providers for victims of out-of-hospital cardiac arrests
|
Yen, Z.-S. and Chen, Y.-T. and Ko, P.C.-I. and Ma, M.H.-M. and Chen, S.-C. and Chen, W.-J. and Lin, F.-Y.; ZUI-SHEN YEN |
| 臺大學術典藏 |
2018-09-10T05:49:25Z |
Cost-effectiveness of different advanced life support providers for victims of out-of-hospital cardiac arrests
|
Yen, Z.-S. and Chen, Y.-T. and Ko, P.C.-I. and Ma, M.H.-M. and Chen, S.-C. and Chen, W.-J. and Lin, F.-Y.; MATTHEW HUEI-MING MA |
| 臺大學術典藏 |
2018-09-10T06:01:23Z |
Cost-effectiveness of different advanced life support providers for victims of out-of-hospital cardiac arrests
|
SHYR-CHYR CHEN; Yen, Z.-S. and Chen, Y.-T. and Ko, P.C.-I. and Ma, M.H.-M. and Chen, S.-C. and Chen, W.-J. and Lin, F.-Y. |
| 臺大學術典藏 |
2018-09-10T06:07:15Z |
Cost-effectiveness of different advanced life support providers for victims of out-of-hospital cardiac arrests
|
Yen, Z.-S. and Chen, Y.-T. and Ko, P.C.-I. and Ma, M.H.-M. and Chen, S.-C. and Chen, W.-J. and Lin, F.-Y.; WEN-JONE CHEN |
| 臺大學術典藏 |
2020-02-07T08:48:48Z |
Cost-effectiveness of different advanced life support providers for victims of out-of-hospital cardiac arrests
|
Lin F.-Y.;Chen W.-J.;Chen S.-C.;MATTHEW HUEI-MING MA;Ko P.C.-I.;Chen Y.-T.;Yen Z.-S.; Yen Z.-S.; Chen Y.-T.; Ko P.C.-I.; MATTHEW HUEI-MING MA; Chen S.-C.; Chen W.-J.; Lin F.-Y. |
| 臺大學術典藏 |
2020-03-19T04:29:16Z |
Cost-effectiveness of different advanced life support providers for victims of out-of-hospital cardiac arrests
|
Zui-Shen Yen;Chen Y.-T.;Ko P.C.-I.;Ma M.H.-M.;Chen S.-C.;Chen W.-J.;Lin F.-Y.; ZUI-SHEN YEN; Chen Y.-T.; Ko P.C.-I.; Ma M.H.-M.; Chen S.-C.; Chen W.-J.; Lin F.-Y. |
| 臺大學術典藏 |
2020-03-25T02:37:01Z |
Cost-effectiveness of different advanced life support providers for victims of out-of-hospital cardiac arrests
|
Lin F.-Y.;Chen W.-J.;SHYR-CHYR CHEN;Ma M.H.-M.;Ko P.C.-I.;Chen Y.-T.;Yen Z.-S.; Yen Z.-S.; Chen Y.-T.; Ko P.C.-I.; Ma M.H.-M.; SHYR-CHYR CHEN; Chen W.-J.; Lin F.-Y. |
| 臺大學術典藏 |
2020-12-21T03:38:34Z |
Cost-effectiveness of different advanced life support providers for victims of out-of-hospital cardiac arrests
|
Chen Y.-T.; Yen Z.-S.; Ko P.C.-I.; MATTHEW HUEI-MING MA; Chen S.-C.; Chen W.-J.; Lin F.-Y. |
| 臺大學術典藏 |
2006 |
Cost-effectiveness of different advanced life support providers for victims of out-of-hospital cardiac arrests
|
Yen Z.-S.;Chen Y.-T.;Ko P.C.-I.;Matthew Huei-Ming Ma;Chen S.-C.;Chen W.-J.;Lin F.-Y.; Yen Z.-S.; Chen Y.-T.; Ko P.C.-I.; MATTHEW HUEI-MING MA; Chen S.-C.; Chen W.-J.; Lin F.-Y. |
| 國立臺灣大學 |
2009 |
Cost-Effectiveness of Different Treatments in Patients with Hepatocellular Carcinoma: A Retrospective Study
|
朱柏青; 陳健弘; 王榮德; 黃景祥; CHU, PO-CHING; CHEN, CHIEN-HUNG; WANG, JUNG-DER; HWANG, JING-SHIANG |
| 臺大學術典藏 |
2020-12-25T08:38:43Z |
Cost-effectiveness of drug-eluting stents in patients with stable coronary artery disease
|
Hung C.-S.; Cheng C.-L.; Chao C.-L.; HSIEN-LI KAO; Chen M.-F.; Lin N.-P. |
| 臺大學術典藏 |
2011 |
Cost-effectiveness of drug-eluting stents in patients with stable coronary artery disease
|
Hung C.-S.; Cheng C.-L.; Chao C.-L.; HSIEN-LI KAO; Chen M.-F.; Lin N.-P. |
| 臺大學術典藏 |
2019-07-16T05:34:47Z |
Cost-Effectiveness of Edoxaban vs. Warfarin in Patients with Atrial Fibrillation Based on Results of the ENGAGE AF - TIMI 48 Trial: Taiwanese Perspective
|
Vilain K.A.;Ming-Chin Yang;Hui Tan E.C.;Wang K.;Li H.;Hsu W.H.;Giugliano R.P.;Cohen D.J.;Magnuson E.A.; Vilain K.A.; MING-CHIN YANG; Hui Tan E.C.; Wang K.; Li H.; Hsu W.H.; Giugliano R.P.; Cohen D.J.; Magnuson E.A. |
| 臺大學術典藏 |
2013 |
Cost-Effectiveness of Expanded Newborn Screening in Texas
|
WEI-CHU CHIE; Hsu, Ching-Fen;Kang, Kun-Tai;Yung-Ling Lee;Wei-Chu Chie; Hsu, Ching-Fen; Kang, Kun-Tai; YUNG-LING LEE |
| 國立臺灣大學 |
2013 |
Cost-Effectiveness of Expanded Newborn Screening in Texas
|
Hsu, Ching-Fen; Kang, Kun-Tai; Lee, Yungling Leo; Chie, Wei-Chu; 季瑋珠; 李永凌 |
| 臺大學術典藏 |
2018-09-10T09:39:39Z |
Cost-effectiveness of expanded newborn screening in Texas
|
Hsu, C.-F. ; Kang, K.-T. ; Leo Lee, Y. ; Chie, W.-C.; WEI-CHU CHIE |
| 臺大學術典藏 |
2022-05-05T09:10:14Z |
Cost-effectiveness of expanded newborn screening in Texas
|
Hsu C.-F.; Kang K.-T.; Leo Lee Y.; WEI-CHU CHIE |
| 國立成功大學 |
2023 |
Cost-effectiveness of first-line immunotherapies for advanced non-small cell lung cancer
|
Yang, S.-C.;Ou, H.-T.;Su, W.-C.;Wang, S.-Y. |
| 國立成功大學 |
2022 |
Cost-effectiveness of First-line Immunotherapy for Non-small Cell Lung Cancer [非小細胞肺癌一線免疫治療的成本效果]
|
Lin, C.-Y.;Yang, S.-C. |
| 中山醫學大學 |
2021 |
Cost-effectiveness of freeze-all policy - A retrospective study based upon the outcome of cumulative live births
|
Chang, JC; Yi, YC; Shen, PS; Guu, HF; Chen, YF; Kung, HF; Chen, LY; Chen, MJ |
| 國立臺灣大學 |
2008 |
Cost-Effectiveness of Gefitinib for First-Line Treatment of Advanced Non- Small Cell Lung Cancer: A Markov Model-Based Analysis
|
劉邦祥; 胡賦強; 王榮德; LIU, PANG-HSIANG; HU, FU-CHANG; WANG, JUNG-DER |
| 嘉南藥理大學 |
2016-05 |
Cost-effectiveness of Gemcitabine Plus Modern Radiotherapy in Locally Advanced Pancreatic Cancer
|
Leung, Henry W. C.; Chan, Agnes L. F.; Muo, Chih-Hsin |
| 國立成功大學 |
2021-01-19 |
Cost-effectiveness of GLP-1 receptor agonists versus insulin for the treatment of type 2 diabetes: a real-world study and systematic review
|
Yang;Chen-Yi;Chen;Ying-Ren;Ou;Huang-Tz;Kuo;Shihchen |
| 國立成功大學 |
2021-12 |
Cost-effectiveness of GLP-1 receptor agonists versus insulin for the treatment of type 2 diabetes: a real-world study and systematic review
|
歐凰姿; Ou, Huang-Tz; Yang, Chen-Yi;Chen, Ying-Ren;Kuo, Shihchen |
| 國立臺灣海洋大學 |
2016 |
Cost-effectiveness of gra nulocyte colony- stimulating factorprophylaxis in chemotherapy-induced febrile neutrop eniaamong breast cancer and Non-Hodgkin’s lymphoma patientsunder Taiwan’s national health insurance system
|
Tsun-Jen Wen; Yu-Wen Wen; Chun-Ru Chien; Shao-Chin Chiang; William Wei-Yuan Hsu; Li-Jiuan Shen; Fei-Yuan Hsiao |
